Completed NA INTERVENTIONAL 3-arm NCT01317134

Endothelial Function in Patients With Pulmonary Arterial Hypertension

Serological and Non-invasive Evaluation of Endothelial Function in Patients With Pulmonary Arterial Hypertension

Sponsor: Actelion

Conditions Genetics Hypertension, Pulmonary Pathophysiology Pulmonary Arterial Hypertension

Interventions Blood Test EndoPAT measurement

Updated 7 times since 2017 Last updated: Aug 8, 2022 Started: Oct 31, 2010 Primary completion: Dec 31, 2014 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01317134, this NA trial focuses on Genetics and Hypertension, Pulmonary and remains completed. Sponsored by Actelion, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Sep 2022 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Actelion
Pfizer
Universitätsklinikum Hamburg-Eppendorf

Data source: Universitätsklinikum Hamburg-Eppendorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany